Jiangsu Hengrui | 600276

Stock Price
72.47
Daily Change
3.82 5.56%
Monthly
17.68%
Yearly
63.22%
Q3 Forecast
71.83

Peers Price Chg Day Year Date
Cspc Pharmaceutical 11.19 0.36 3.32% 140.13% Sep/05
Sino Biopharmaceutical 8.91 0.52 6.20% 183.76% Sep/05
Sh Fosun Pharma 30.19 0.86 2.93% 34.12% Sep/05
Zhangzhou Pientzehuang Pharmaceutical 203.87 0.94 0.46% 0.69% Sep/05
Kangmei Pharma 2.03 0 0% 15.34% Sep/05
Sh Pharmaceutical 18.33 0.07 0.38% -4.78% Sep/05
WuXi AppTec 107.40 5.46 5.36% 176.80% Sep/05

Indexes Price Day Year Date
SHANGHAI 3813 46.64 1.24% 37.84% Sep/05
SHANGHAI 50 2942 31.75 1.09% 29.98% Sep/05

Jiangsu Hengrui Me. traded at 72.47 this Friday September 5th, increasing 3.82 or 5.56 percent since the previous trading session. Looking back, over the last four weeks, Jiangsu Hengrui gained 17.68 percent. Over the last 12 months, its price rose by 63.22 percent. Looking ahead, we forecast Jiangsu Hengrui Me. to be priced at 71.83 by the end of this quarter and at 69.92 in one year, according to Trading Economics global macro models projections and analysts expectations.

Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.